Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cannabis Innovation Center is an Israel-based medical cannabis innovation group focused on cannabinoid-based drug development and related biotech ventures. Publicly available descriptions characterize it as a portfolio or group of IP-protected startup companies with an emphasis on pharmaceutical cannabis research, preclinical and clinical development support, and commercialization infrastructure. Reported affiliated companies include Stero Biotechs, CannaLean Biotechs, CannaMore Biotechs, Cannadu, and BioSeed. The organization appears to function more as a holding, platform, and venture-building ecosystem than as a single-asset therapeutic company. Evidence suggests it operates in partnership-rich settings connected to Israeli clinical and research networks, but detailed pipeline, financing, and corporate disclosures are limited in public sources.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cannabis Innovation Center.